Cas:2197-01-5 3,3′-Diethylthiacyanine iodide manufacturer & supplier

We serve Chemical Name:3,3′-Diethylthiacyanine iodide CAS:2197-01-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,3′-Diethylthiacyanine iodide

Chemical Name:3,3′-Diethylthiacyanine iodide
CAS.NO:2197-01-5
Synonyms:MFCD00050309;(2E)-3-ethyl-2-[(3-ethyl-1,3-benzothiazol-3-ium-2-yl)methylidene]-1,3-benzothiazole,iodide;EINECS 218-593-1
Molecular Formula:C19H19IN2S2
Molecular Weight:466.40200
HS Code:

Physical and Chemical Properties:
Melting point:300ºC
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:65.29000
Exact Mass:466.00300
LogP:1.35870

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811 6.1/PG 3
Packing Group:


Contact us for information like MFCD00050309 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 218-593-1 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 218-593-1 Use and application,EINECS 218-593-1 technical grade,usp/ep/jp grade.


Related News: A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge. (13S)-3-hydroxy-1,13-dimethyl-(13r,14t)-11,12,13,14,15,16-hexahydro-cyclopenta[a]phenanthren-17-one manufacturers Symonds’ board has backed Walmsley’s leadership. In response to Elliott’s open attack earlier this month, the GSK board said it “strongly believes” Walmsley is the “right leader” for the company, citing “widespread and strong support” from GSK’s largest shareholders for Walmsley’s newly unveiled plan to improve the company’s performance. RNA (human immunodeficiency virus 1 isolate PP clone E11 gene envfragment) suppliers UK-headquartered Verona announced at the beginning of the year that it had completed enrolment in a pilot study evaluating the efficacy of ensifentrine delivered via pressurised metered-dose inhaler (pMDI) formulation in patients hospitalised with COVID-19. 1-(23-hexaoxan-2-yl)-5-(5-hydroperoxy-13,24,33,43,54,63-hexaoxin-2-yl)-24,44-pentaoxidane-2,4-dione vendor & factory.